Delivery Order SPE2DB22D3401-SPE2DB24FT3DR
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,054.96 firm fixed-price contract is for the delivery of Montelukast Sodium 4 mg granules, a medication used to treat asthma and allergies. The contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Montelukast Sodium 10 mg tablets. The award, valued at $1,171.19, is a firm fixed-price delivery order contract with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,363.84 Firm Fixed Price Delivery Order is for the supply of 4558010285 - Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,003.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566698224 units of Montelukast Sodium 10 mg tablets, a medication used to treat conditions such as asthma and allergies. The contract has an ultimate completion date of December 13, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is...
- This federal contract award, SPE2DB22D1002|SPE2DB24FKYA6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg Chewable Tablets, a medication used to treat asthma and allergy symptoms. The contract is a firm fixed-price delivery order with a total ceiling value of $2,868.26 and an ultimate completion date of February 14, 2024....
- This federal contract award, valued at $1,125.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg chewable tablets in 90-count packages, with a completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 1,000 bottles of Montelukast Sodium 10 mg tablets, a medication used to treat asthma and allergies. The total ceiling value of the contract is $1,727.93, and it is a firm fixed-price delivery order with an ultimate completion date of August 8, 2024. This order is not associated with a set-aside program....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg chewable tablets, a medication used to treat asthma and allergies. The contract has a firm fixed price, a ceiling value of $1,495.97, and an ultimate completion date of July 16, 2025. The contract is not set aside for any specific business type....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Montelukast Sodium 5 mg Chewable Tablets in quantities of 90s, with a ceiling value of $2,505.94 and a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $936 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of montelukast sodium at 10 mg each. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide pharmaceutical products to support DLA and Department of Defense requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 31 to August 1, 2023. No...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT3DRDelivery Order
This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,210.64 firm fixed-price delivery order is for 4,564,702,344 units of Montelukast Sodium 4 mg Granules, a medication used to treat asthma and allergies. The contract has a completion date of May 24, 2024 and was awarded on May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/23/24 |